Genomics

Dataset Information

0

Retinoic acid rewires the adrenergic core regulatory circuitry of neuroblastoma but can be subverted by enhancer hijacking of MYC or MYCN (RNA-Seq)


ABSTRACT: Neuroblastoma cell identity depends on a core regulatory circuit (CRC) of transcription factors that incorporate MYCN to drive the oncogenic gene expression program. For neuroblastomas dependent on the adrenergic CRC, treatment with retinoids can inhibit cell growth and induce differentiation in both primary neuroblastomas and cell lines; however, the underlying mechanisms remain unclear. Here we show that when MYCN-amplified neuroblastomas cells are treated with all-trans retinoic acid (ATRA), they undergo modifications of histone H3K27 acetylation and methylation that decommission super-enhancers driving the expression of PHOX2B and GATA3, together with the activation of new super-enhancers that drive high levels of expression of MEIS1, HIC1 and SOX4. These findings indicate that treatment with ATRA can reprogram the enhancer landscape to collapse the adrenergic CRC, which downregulates MYCN expression, while upregulating a new “retino-sympathetic” CRC that causes proliferative arrest and sympathetic differentiation. Thus, we provide mechanisms that account for the beneficial effects of retinoids against high-risk neuroblastoma and explain the rapid downregulation of expression of MYCN despite massive levels of gene amplification.

ORGANISM(S): Homo sapiens

PROVIDER: GSE155000 | GEO | 2021/10/25

REPOSITORIES: GEO

Similar Datasets

2021-10-25 | GSE154999 | GEO
2021-10-25 | GSE169616 | GEO
2024-03-04 | GSE240505 | GEO
2024-03-04 | GSE240504 | GEO
2023-04-25 | GSE224158 | GEO
2023-02-01 | GSE224244 | GEO
2023-02-01 | GSE224242 | GEO
2023-02-01 | GSE224241 | GEO
2023-05-10 | PXD039332 | Pride
2020-12-18 | GSE163428 | GEO